Article
The escalating challenge of vancomycin resistance in Staphylococcus aureus.
Current drug targets. Infectious disorders - 1 Dec 2004
Pfeltz R F, Wilkinson B J
Abstract excerpt
The glycopeptide antibiotic vancomycin is considered indispensable for the treatment of multidrug-resistant Staphylococcus aureus infections, and so the acquisition by these organisms of transmissible glycopeptide resistance elements from enterococci had been anticipated with apprehension. It was therefore a considerable surprise when vancomycin-intermediate S. aureus (VISA) clinical isolates were reported in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
